Zhiliang Gao

15PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityCardiology (incl. cardiovascular diseases)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 03, 2026
Sorafenib enforces HIV-1 latency by selectively inhibiting PKC-driven STAT1/3 serine 727 phosphorylation.

|May 23, 2026
Acute-on-chronic liver failure-associated CD45+ EPCs reduced survival via promoting fatty acid β-oxidation in vascular endothelial cells.

|Mar 20, 2025
Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss.

Na Gao, Haishi Wu, Bin Li

|Jun 26, 2024
Serum sPD-1 and sPD-L1 as predictive biomarkers for HBsAg clearance in HBeAg-negative CHB patients undergoing IFN-based therapy.

Xiyao Chen, Boxiang Zhang, Xin Song

|Apr 25, 2024
Interferon-γ+ Th1 activates intrahepatic resident memory T cells to promote HBsAg loss by inducing M1 macrophage polarization.

Lili Wu, Hong Deng, Xiao Feng

|Aug 30, 2023
Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg-positive patients with functional cure following PEG-IFN-based therapy.

Na Gao, Guiwen Guan, Ganlin Xu

Pageof 3

Frequent Collaborators

5 joint publications

Na Gao

4 joint publications

Qiyi Zhao

3 joint publications

Liang Peng

3 joint publications

Haishi Wu